UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
15(d) of the Securities Exchange Act of 1934
For
the quarterly period ended
15(d) of the Securities Exchange Act of 1934
For the transition period from __ to __
Commission
File Number:
(Exact name of registrant as specified in its charter)
| | ||
| (State or other jurisdiction of | (I.R.S. Employer Identification No.) | |
| Incorporation or organization) |
(Address of principal executive offices)
(Registrant’s telephone number)
Securities registered pursuant to Section 12(b) of the Exchange Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate
by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. ☒
Indicate
by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| Large Accelerated Filer | ☐ | Accelerated Filer | ☐ |
| ☒ | Smaller Reporting Company | ||
| Emerging Growth Company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes
As
of April 7, 2022, there were
TSR, INC. AND SUBSIDIARIES
INDEX
i
Part I. Financial Information
Item 1. Financial Statements
TSR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
| February 28, 2022 | May 31, 2021 | |||||||
| ASSETS | (Unaudited) | (see Note 1) | ||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Marketable securities | ||||||||
| Accounts receivable, net of allowance for doubtful accounts of $ | ||||||||
| Other receivables | ||||||||
| Prepaid expenses | ||||||||
| Prepaid and recoverable income taxes | ||||||||
| Total Current Assets | ||||||||
| Equipment and leasehold improvements, net of accumulated depreciation and amortization of $ | ||||||||
| Other assets | ||||||||
| Right-of-use assets | ||||||||
| Intangible assets, net | ||||||||
| Goodwill | ||||||||
| Deferred income taxes | ||||||||
| Total Assets | $ | $ | ||||||
| LIABILITIES AND EQUITY | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable and other payables | $ | $ | ||||||
| Accrued expenses and other current liabilities | ||||||||
| Advances from customers | ||||||||
| Credit facility | ||||||||
| Operating lease liabilities - current | ||||||||
| Legal settlement payable - current | ||||||||
| Total Current Liabilities | ||||||||
| Operating lease liabilities, net of current portion | ||||||||
| Legal settlement payable, net of current portion | ||||||||
| SBA Paycheck Protection Program loan payable | ||||||||
| Total Liabilities | ||||||||
| Commitments and contingencies | ||||||||
| Equity: | ||||||||
| TSR, Inc.: | ||||||||
| Preferred stock, $ | ||||||||
| Common stock, $ | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Less: Treasury stock, | ||||||||
| Total TSR, Inc. Equity | ||||||||
| Noncontrolling interest | ||||||||
| Total Equity | ||||||||
| Total Liabilities and Equity | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Page 1
TSR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three Months and Nine Months Ended February 28, 2022 and February 28, 2021
(UNAUDITED)
| Three Months Ended February 28, | Nine Months Ended February 28, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Revenue, net | $ | $ | $ | $ | ||||||||||||
| Cost of sales | ||||||||||||||||
| Selling, general and administrative expenses | ||||||||||||||||
| Income (loss) from operations | ( | ) | ( | ) | ( | ) | ||||||||||
| Other income (expense): | ||||||||||||||||
| Interest expense, net | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Gain on PPP Loan and interest forgiveness | ||||||||||||||||
| Unrealized gain (loss) on marketable securities, net | ( | ) | ( | ) | ( | ) | ||||||||||
| Income (loss) before income taxes | ( | ) | ( | ) | ( | ) | ||||||||||
| Benefit from income taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Consolidated net income (loss) | ( | ) | ( | ) | ( | ) | ||||||||||
| Less: Net income attributable to noncontrolling interest | ||||||||||||||||
| Net income (loss) attributable to TSR, Inc. | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||
| Basic net income (loss) per TSR, Inc. common share | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||
| Diluted net income (loss) per TSR, Inc. common share | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | ||||||
| Basic weighted average number of common shares outstanding | ||||||||||||||||
| Diluted weighted average number of common shares outstanding | ||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Page 2
TSR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
For the Three Months and Nine Months Ended February 28, 2022 and February 28, 2021
(UNAUDITED)
| Shares of common stock | Common stock | Additional paid-in capital | Retained earnings | Treasury stock | TSR, Inc. equity | Non- controlling interest | Total equity | |||||||||||||||||||||||||
| Balance at May 31, 2020 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
| Net income attributable to noncontrolling interest | - | |||||||||||||||||||||||||||||||
| Net loss attributable to TSR, Inc. | - | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
| Balance at Aug. 31, 2020 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
| Net loss attributable to noncontrolling interest | - | ( | ) | ( | ) | |||||||||||||||||||||||||||
| Net loss attributable to TSR, Inc. | - | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
| Balance at Nov. 30, 2020 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
| Net income attributable to noncontrolling interest | - | |||||||||||||||||||||||||||||||
| Non-cash stock compensation | - | |||||||||||||||||||||||||||||||
| Net loss attributable to TSR, Inc. | - | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
| Balance at Feb. 28, 2021 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Page 3
TSR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
For the Three Months and Nine Months Ended February 28, 2022 and February 28, 2021
(UNAUDITED)
| Shares of common stock | Common stock | Additional paid-in capital | Retained earnings | Treasury stock | TSR, Inc. equity | Non- controlling interest | Total equity | |||||||||||||||||||||||||
| Balance at May 31, 2021 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
| Net income attributable to noncontrolling interest | - | |||||||||||||||||||||||||||||||
| Distribution to noncontrolling interest | - | ( | ) | ( | ) | |||||||||||||||||||||||||||
| Non-cash stock compensation | - | |||||||||||||||||||||||||||||||
| Net income attributable to TSR, Inc. | - | |||||||||||||||||||||||||||||||
| Balance at Aug. 31, 2021 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
| Net income attributable to noncontrolling interest | - | |||||||||||||||||||||||||||||||
| Distribution to noncontrolling interest | - | ( | ) | ( | ) | |||||||||||||||||||||||||||
| Non-cash stock compensation | - | |||||||||||||||||||||||||||||||
| Net income attributable to TSR, Inc. | - | |||||||||||||||||||||||||||||||
| Balance at Nov. 30, 2021 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
| Net income attributable to noncontrolling interest | - | |||||||||||||||||||||||||||||||
| Proceeds of sales of stock through ATM | - | |||||||||||||||||||||||||||||||
| Non-cash stock compensation | - | |||||||||||||||||||||||||||||||
| Vested stock awards and taxes paid | ( | ) | - | ( | ) | ( | ) | |||||||||||||||||||||||||
| Net loss attributable to TSR, Inc. | - | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
| Balance at Feb. 28, 2022 | $ | $ | $ | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Page 4
TSR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For The Nine Months Ended February 28, 2022 and February 28,
2021
(UNAUDITED)
| Nine Months Ended February 28, | ||||||||
| 2022 | 2021 | |||||||
| Cash flows from operating activities: | ||||||||
| Consolidated net income (loss) | $ | $ | ( | ) | ||||
| Adjustments to reconcile consolidated net income (loss) to net cash (used in) provided by operating activities: | ||||||||
| Depreciation and amortization | ||||||||
| Unrealized loss on marketable securities, net | ||||||||
| Deferred income taxes | ( | ) | ||||||
| Non-cash lease recovery | ( | ) | ( | ) | ||||
| Non-cash Right-of-use asset impairment charge | ||||||||
| Forgiveness of principal and accrued interest on SBA PPP loan | ( | ) | ||||||
| Non-cash stock-based compensation expense | ||||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | ( | ) | ( | ) | ||||
| Other receivables | ( | ) | ( | ) | ||||
| Prepaid expenses | ( | ) | ( | ) | ||||
| Prepaid and recoverable income taxes | ( | ) | ||||||
| Other assets | ( | ) | ||||||
| Accounts payable, other payables, accrued expenses and other current liabilities | ||||||||
| Advances from customers | ( | ) | ||||||
| Legal settlement payable | ( | ) | ||||||
| Net cash (used in) provided by operating activities | ( | ) | ||||||
| Cash flows from investing activities: | ||||||||
| Purchase of Geneva Consulting Group, Inc., net of cash acquired of $ | ( | ) | ||||||
| Purchases of equipment and leasehold improvements | ( | ) | ( | ) | ||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities: | ||||||||
| Net repayments on Credit Facility | ( | ) | ( | ) | ||||
| Net proceeds from ATM stock sales | ||||||||
| Tax withholding from vested stock awards | ( | ) | ||||||
| Distribution to noncontrolling interest | ( | ) | ||||||
| Net cash provided by (used in) financing activities | ( | ) | ||||||
| Net decrease in cash and cash equivalents | ( | ) | ( | ) | ||||
| Cash and cash equivalents at beginning of period | ||||||||
| Cash and cash equivalents at end of period | $ | $ | ||||||
| Supplemental disclosures of cash flow data: | ||||||||
| Income taxes paid | $ | $ | ||||||
| Non-cash investing and financing activities: | ||||||||
| Right-of-use asset and operating lease liability | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Page 5
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 1. | Basis of Presentation |
The accompanying condensed consolidated interim financial statements include the accounts of TSR, Inc. and its subsidiaries. Unless otherwise stated or the context otherwise requires, the terms “we,” “us,” “our,” and the “Company” refer to TSR, Inc. and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. The condensed balance sheet as of May 31, 2021, which has been derived from audited financial statements, and the unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applying to interim financial information and with the instructions to Form 10-Q of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures required by accounting principles generally accepted in the United States of America and normally included in the Company’s annual financial statements have been condensed or omitted. These condensed consolidated interim financial statements as of and for the three months and nine months ended February 28, 2022 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring adjustments) necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. The results of operations for the interim periods presented are not necessarily indicative of the results that might be expected for future interim periods or for the full year ending May 31, 2022. These condensed consolidated interim financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended May 31, 2021.
| 2. | Net Income (Loss) Per Common Share |
Basic net income (loss) per common
share is computed by dividing net income (loss) available to common stockholders of TSR by the weighted average number of common shares
outstanding during the reporting period, excluding the effects of any potentially dilutive securities. During the quarter ended February
28, 2021, the Company granted time and performance vesting restricted stock awards under its 2020 Equity Incentive Plan (see Note 17 for
further information). Diluted earnings per share gives effect to all potentially dilutive common shares outstanding during the reporting
period. The common stock equivalents associated with these restricted stock awards of
| 3. | Cash and Cash Equivalents |
The Company considers short-term highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. Cash and cash equivalents were comprised of the following as of February 28, 2022 and May 31, 2021:
| February 28, 2022 | May 31, 2021 | |||||||
| Cash in banks | $ | $ | ||||||
| Money market funds | ||||||||
| $ | $ | |||||||
Page 6
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 4. | Fair Value of Financial Instruments |
Accounting Standards Codification (“ASC”) 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”), defines fair value, establishes a framework for measuring fair value under accounting principles generally accepted in the United States of America (“GAAP”) and provides for expanded disclosure about fair value measurements. ASC 820-10 applies to all other accounting pronouncements that require or permit fair value measurements.
The Company determines or calculates the fair value of financial instruments using quoted market prices in active markets when such information is available or using appropriate present value or other valuation techniques, such as discounted cash flow analyses, incorporating available market discount rate information for similar types of instruments while estimating for non-performance and liquidity risk. These techniques are significantly affected by the assumptions used, including the discount rate, credit spreads and estimates of future cash flows.
Assets and liabilities typically recorded at fair value on a non-recurring basis to which ASC 820-10 applies include:
| ● | non-financial assets and liabilities initially measured at fair value in an acquisition or business combination, and | |
| ● | long-lived assets measured at fair value due to an impairment assessment under ASC 360-10-15, Impairment or Disposal of Long-Lived Assets. |
This topic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and establishes a three-level hierarchy, which encourages an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820-10 requires that assets and liabilities recorded at fair value be classified and disclosed in one of the following three categories:
| ● | Level 1 - inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. | |
| ● | Level 2 - inputs utilize other-than-quoted prices that are observable, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and inputs such as interest rates and yield curves that are observable at commonly quoted intervals. | |
| ● | Level 3 - inputs are unobservable and are typically based on the Company’s own assumptions, including situations where there is little, if any, market activity. Both observable and unobservable inputs may be used to determine the fair value of positions that are classified within the Level 3 classification. |
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company classifies such financial assets or liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
ASC Topic 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. For cash and cash equivalents, accounts receivable, accounts and other payables, accrued liabilities and advances from customers, the amounts presented in the condensed consolidated financial statements approximate fair value because of the short-term maturities of these instruments.
| 5. | Marketable Securities |
The Company has characterized its investments in marketable securities, based on the priority of the inputs used to value the investments, into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and lowest priority to unobservable inputs (Level 3). If the inputs used to measure the investments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
Investments recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs to valuation techniques as follows:
| ● | Level 1 - These are investments where values are based on unadjusted quoted prices for identical assets in an active market the Company has the ability to access. | |
| ● | Level 2 - These are investments where values are based on quoted market prices that are not active or model derived valuations in which all significant inputs are observable in active markets. | |
| ● | Level 3 - These are investments where values are derived from techniques in which one or more significant inputs are unobservable. |
Page 7
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
The following are the major categories of assets measured at fair value on a recurring basis as of February 28, 2022 and May 31, 2021 using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2) and significant unobservable inputs (Level 3):
| February 28, 2022 | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
| Equity Securities | $ | $ | $ | $ | ||||||||||||
| May 31, 2021 | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
| Equity Securities | $ | $ | - | $ | - | $ | ||||||||||
The Company’s equity securities are classified as trading securities, which are carried at fair value, as determined by quoted market prices, which is a Level 1 input, as established by the fair value hierarchy. The related unrealized gains and losses are included in earnings. The Company’s marketable securities at February 28, 2022 and May 31, 2021 are summarized as follows:
| February 28, 2022 | Amortized Cost | Gross Unrealized Holding Gains | Gross Unrealized Holding Losses | Recorded Value | ||||||||||||
| Equity Securities | $ | $ | $ | $ | ||||||||||||
| May 31, 2021 | Amortized Cost | Gross Unrealized Holding Gains | Gross Unrealized Holding Losses | Recorded Value | ||||||||||||
| Equity Securities | $ | $ | $ | $ | ||||||||||||
The Company’s investments in marketable securities consist primarily of investments in equity securities. Market values were determined for each individual security in the investment portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, and the Company’s ability and intent to hold the investment for a period of time, which may be sufficient for anticipated recovery in market values.
Page 8
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 6. | Other Matters |
From time to time, the Company is party to various lawsuits, some involving material amounts. Management is not aware of any lawsuits that would have a material adverse impact on the consolidated financial position of the Company except for the litigation disclosed elsewhere in the report, including Notes 9, 10, 16 and 19 to the Condensed Consolidated Financial Statements and in the section titled “Item 1, Legal Proceedings” in Part II of this report.
| 7. | Leases |
The Company leases the space for its three offices in New York City, Hauppauge and New Jersey. Under ASC 842, at contract inception we determine whether the contract is or contains a lease and whether the lease should be classified as an operating or finance lease. Operating leases are in right-of-use assets and operating lease liabilities are in our condensed consolidated balance sheets.
The Company’s leases for its three offices are classified as operating leases.
In addition to the monthly base amounts in the lease agreements, the Company is required to pay real estate taxes and operating expenses during the lease terms.
For the nine months ended February
28, 2022 and 2021, the Company’s operating lease expense for these leases was $
Future minimum lease payments under non-cancellable operating leases as of February 28, 2022 were as follows:
| Twelve Months Ending February 28, | ||||
| 2023 | $ | |||
| 2024 | ||||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| Thereafter | ||||
| Total undiscounted operating lease payments | ||||
| Less imputed interest | ||||
| Present value of operating lease payments | $ | |||
Page 9
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
The following table sets forth the right-of-use assets and operating lease liabilities as of February 28, 2022:
| Assets | ||||
| Right-of-use assets, net | $ | |||
| Liabilities | ||||
| Current operating lease liabilities | $ | |||
| Long-term operating lease liabilities | ||||
| Total operating lease liabilities | $ | |||
The weighted average remaining lease
term for the Company’s operating leases is
| 8. | Credit Facility |
On November 27,
2019, TSR closed on a revolving credit facility (the “Credit Facility”) pursuant to a Loan and Security Agreement with Access
Capital, Inc. (the “Lender”) that initially provided up to $
TSR expects to
utilize the Credit Facility for working capital and general corporate purposes. The maximum amount that may now be advanced under the
Credit Facility at any time shall not exceed $
Advances under the Credit Facility accrue interest at a rate per annum equal to (x) the “base rate” or “prime rate” announced by Citibank, N.A. from time to time, which shall be increased or decreased, as the case may be, in an amount equal to each increase or decrease in such “base rate” or “prime rate,” plus (y) 1.75%. The prime rate as of February 28, 2022 was 3.25%, indicating an interest rate of 5.0% on the line of credit. The initial term of the Credit Facility is five years, which shall automatically renew for successive five-year periods unless either TSR or the Lender gives written notice to the other of termination at least 60 days prior to the expiration date of the then-current term.
TSR is obliged to satisfy certain financial covenants and minimum borrowing requirements under the Credit Facility, and to pay certain fees, including prepayment fees, and provide certain financial information to the Lender. The Company was in compliance with all applicable covenants at February 28, 2022.
As of February 28, 2022, the net borrowings
outstanding against this line of credit facility were $
Page 10
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 9. | Termination of Former CEO |
The Company terminated Christopher
Hughes, the former Chief Executive Officer of the Company (“Hughes”), effective February 29, 2020 for “Cause”
as defined in Section 6(a) of his Amended and Restated Employment Agreement dated August 9, 2018 (the “Employment Agreement”).
Despite having already been terminated from employment, on March 2, 2020, the Company received a letter from Mr. Hughes, providing notice
of his intent to resign for “Good Reason” as defined in Section 7(c) of the Employment Agreement pursuant to which he claimed
to be entitled to the “Enhanced Severance Amount” under the Employment Agreement. Hughes filed a complaint against the Company
in the Supreme Court of the State of New York in March 2020 alleging two causes of action:
In October 2021, the Company and Hughes
agreed through mediation to settle this matter. In order to avoid lengthy and costly litigation and discovery expenses, the Company has
paid Hughes $
| 10. | Legal Settlement with Investor |
On April 1, 2020,
the Company entered into a binding term sheet (“Term Sheet”) with Zeff Capital, L.P. (“Zeff”) pursuant to which
it agreed to pay Zeff an amount of $
| 11. | COVID-19 |
The COVID-19 outbreak in the United States has caused business disruption including mandated and voluntary closing of various businesses. While the disruption is currently expected to be temporary, there is considerable uncertainty around the duration of the closings and the impact of the pandemic on our business. Therefore, the Company expects this matter to continue to negatively impact its operating results in future periods. The full financial impact and duration cannot be reasonably estimated at this time.
Page 11
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 12. | Paycheck Protection Program Loan |
On April 15, 2020, the Company received
loan proceeds of $
In March 2021, the Company submitted
a PPP Loan Forgiveness application to the SBA through the PPP Lender. On July 7, 2021, the Company received notification from the PPP
Lender that the SBA approved the Company’s application for forgiveness of the entire principal amount of the PPP Loan plus accrued
interest. The PPP Lender will apply the forgiveness amount to satisfy the PPP Loan. The Company has no further obligations with respect
to the PPP Loan. The Company recognized “Other Income” of $
| 13. | Geneva Consulting Group Acquisition |
On September 1, 2020, the Company completed the acquisition of all of the outstanding stock of Geneva Consulting Group, Inc., a New York corporation (“Geneva”) and provider of temporary and permanent information technology personnel based in Port Washington, New York. The stock of Geneva was purchased from the three shareholders of Geneva (the “Sellers”), none of which had, or will have following the acquisition, a material relationship with the Company or its affiliates.
The purchase price for the shares of Geneva was comprised of the following: (i) $1,452,000 in cash paid to Sellers at the closing of the acquisition, (ii) an amount of $748,000, which was equal to the amount of Geneva’s loan under the PPP that was not assumed by the Company and was substantially forgiven by the SBA, (iii) an amount up to $300,000, originally payable paid as an earnout payment in part in February 2021 and in part in August 2021 (the “Earnout Payments”), (iv) bonus payments payable in $10,000 increments, (v) $747,000 for the net working capital of Geneva as of closing and (vi) other purchase price adjustments of which $36,000 has been paid to date. Any Earnout Payments and bonus payments were to be determined based upon the achievement of certain criteria relating to the number the Company’s contractors working full-time at the Company’s client locations on such dates.
The initial Earnout Payments and bonus payment liability was valued at its fair value using an option pricing based approach with a risk-neutral framework using Black Scholes due to the option-like nature of the earnout payment structure (Level 3 of the fair value hierarchy). The Earnout Payments were revalued quarterly prior to the resolution discussed below, using a present value approach and any resulting increase or decrease was recorded into selling, general and administrative expenses. Any changes in the amount of the actual results and forecasted scenarios could impact the fair value. Significant judgment was employed in determining the appropriateness of the assumptions used in calculating the fair value of the Earnout Payments as of the acquisition date and subsequent period ends.
On March 17, 2021, the Company entered
into an agreement with the Sellers’ representatives pursuant to which the parties agreed to resolve certain interpretive differences
regarding the Sellers’ entitlement to the bonus payments described above.
Page 12
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
The acquisition was accounted for as an acquisition of a business in accordance with the acquisition method of accounting. The acquired assets and assumed liabilities were recorded at their fair values. The Company determined the fair values with the assistance of valuations performed by an independent third-party specialist.
The Company incurred approximately
$
The following table summarizes the components of the purchase price at fair values at September 1, 2020:
| Cash consideration paid to date | $ | |||
| Estimated earnout and other liabilities | ||||
| Total purchase price | $ |
The following table summarizes the allocation of purchase price at estimated fair values at September 1, 2020:
| Cash | $ | |||
| Accounts receivable | ||||
| Prepaid expenses | ||||
| Intangible assets (see Note 15) | ||||
| Goodwill | ||||
| Accrued expenses | ( | ) | ||
| Net assets | $ |
The following unaudited pro forma financial information presents the combined operating results of the Company and Geneva as if the acquisition had occurred as of the beginning of the earliest period presented. Pro forma data is subject to various assumptions and estimates and is presented for informational purposes only. This pro forma data does not purport to represent or be indicative of the consolidated operating results that would have been reported had the transaction been completed as described herein, and the data should not be taken as indicative of future operating results.
Unaudited pro forma financial information assuming the acquisition of Geneva as of June 1, 2020 is presented in the following table (in thousands):
| Nine Months Ended | ||||
| February 28, 2021 | ||||
| Revenue | $ | |||
| Net loss | $ | ( | ) | |
| Diluted loss per share | $ | ( | ) | |
Page 13
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 14. | Goodwill |
Goodwill is recorded when the purchase price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Goodwill is not amortized but is subject to impairment analysis at least once annually or more frequently upon the occurrence of an event or when circumstances indicate that the carrying amount of a unit is greater than its fair value. The annual test of goodwill was performed as of September 1, 2021 and no impairment was found.
| 15. | Intangible Assets |
The Company amortizes its intangible assets over their estimated useful lives and will review these assets for impairment when there is evidence that events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If intangible assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.
Intangible assets are as follows:
| May 31, | February 28, | |||||||||||
| 2021 | Amortization | 2022 | ||||||||||
| $ | $ | $ | ||||||||||
| $ | $ | $ | ||||||||||
No instances of triggering events or impairment indicators were identified at February 28, 2022.
| 16. | Related Party Transactions |
On January 5, 2021, the members of
the Board of Directors of the Company other than Robert Fitzgerald approved providing a waiver to QAR Industries, Inc. for its contemplated
acquisition of shares owned by Fintech Consulting LLC under the Company’s then existing rights agreement (which covered a now non-existent
class of Class A preferred stock) so that a distribution date would not occur under such agreement as a result of the acquisition. QAR
Industries, Inc. and Fintech Consulting LLC were both principal stockholders of the Company, each owning more than
On February 3, 2021, the transaction
was completed and QAR Industries, Inc. purchased
Page 14
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 17. | Stock-based Compensation Expense |
On January 28, 2021, the Company granted
| 18. | Common Stock |
Our certificate of incorporation, as
amended, authorizes the issuance of up to
On October 8, 2021, the Company filed
an automatic shelf registration statement on Form S-3 (File No. 333-260152) (the “2021 TSRI Shelf”) which contains
During the three months and nine months
ended February 28, 2022, we sold an aggregate of
The 2021 TSRI Shelf is currently our only active shelf-registration statement. We may offer TSR common stock registered under the 2021 TSRI Shelf from time to time in response to market conditions or other circumstances if we believe such a plan of financing is in the best interests of our stockholders. We believe that the 2021 TSRI Shelf provides us with the flexibility to raise additional capital to finance our operations as needed. However, there is no assurance we will be successful in doing so.
Page 15
TSR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
| 19. | Pending Legal Issue |
On December 1, 2021, Fintech Consulting LLC filed a complaint against the Company in the United States District Court for the District of New Jersey. The named Defendants in the complaint are the Company, QAR Industries, Inc., a shareholder of TSR (“QAR”), Robert E. Fitzgerald, a director and shareholder of TSR and the President, director and a shareholder of QAR (“Fitzgerald”), and Bradley Tirpak, a shareholder and the chairman of the board of directors of TSR (“Tirpak”). The complaint purports to assert claims against the Defendants under state law and Section 10(b) of the Exchange Act in connection with a Share Purchase Agreement, dated January 31, 2021, by and between the Plaintiff, as the seller of shares of TSR’s common stock, and QAR and Tirpak, as the purchasers of such shares (the “SPA”). The plaintiff seeks (i) judgment declaring the transactions represented by the SPA null and avoid and returning the shares; (ii) judgment cancelling the SPA and returning the shares in exchange for return of the purchase price; (iii) judgement unwinding the transaction; (iv) compensatory damages; (v) punitive damages; (vi) pre-judgment interest; (vii) costs of suit including attorneys’ fees; and (viii) such other relief as the Court may find appropriate. See Note 16 to the Condensed Consolidated Unaudited Financial Statements elsewhere in this report and the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2021 for more information.
The Company believes the action described above to be without merit and intends to vigorously defend its interests. However, the Company may incur significant additional legal expenses as it pursues a vigorous defense against this action.
While the Company believes the action to be without merit, no assurances can be given as to: (i) the outcome of this or other legal proceedings and (ii) the related impact of an unanticipated adverse outcome of these proceedings on the Company’s financial condition, results of operations or near-term liquidity.
Page 16
TSR, INC. AND SUBSIDIARIES
MANAGEMENT DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and the notes to such financial statements.
Forward-Looking Statements
Certain statements contained in Management’s Discussion and Analysis of Financial Condition and Results of Operations, including statements concerning the Company’s plans, future prospects and the Company’s future cash flow requirements are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projections in the forward-looking statements due to known and unknown risks and uncertainties, including but not limited to the following: the statements concerning the success of the Company’s plan for growth, both internally and through the previously announced pursuit of suitable acquisition candidates; the successful integration of announced and completed acquisitions and any anticipated benefits therefrom; the impact of adverse economic conditions on client spending which has a negative impact on the Company’s business, which includes, but is not limited to, the current adverse economic conditions associated with the COVID-19 global health pandemic and the associated financial crisis, stay-at-home and other orders, which may significantly reduce client spending and which may have a negative impact on the Company’s business; risks relating to the competitive nature of the markets for contract computer programming services; the extent to which market conditions for the Company’s contract computer programming services will continue to adversely affect the Company’s business; the concentration of the Company’s business with certain customers; uncertainty as to the Company’s ability to maintain its relations with existing customers and expand its business; the impact of changes in the industry, such as the use of vendor management companies in connection with the consultant procurement process; the increase in customers moving IT operations offshore; the Company’s ability to adapt to changing market conditions; the risks, uncertainties and expense of the legal proceedings to which the Company is a party; and other risks and uncertainties set forth in the Company’s filings with the Securities and Exchange Commission. The Company is under no obligation to publicly update or revise forward-looking statements.
Results of Operations
The following table sets forth, for the periods indicated, certain financial information derived from the Company’s condensed consolidated statements of operations. There can be no assurance that trends in operating results will continue in the future.
Three months ended February 28, 2022 compared with three months ended February 28, 2021:
| (Dollar amounts in thousands) Three Months Ended | ||||||||||||||||
| February 28, 2022 | February 28, 2021 | |||||||||||||||
| Amount | % of Revenue | Amount | % of Revenue | |||||||||||||
| Revenue, net | $ | 24,383 | 100.0 | % | $ | 17,160 | 100.0 | % | ||||||||
| Cost of sales | 20,590 | 84.4 | % | 14,415 | 84.0 | % | ||||||||||
| Gross profit | 3,793 | 15.6 | % | 2,745 | 16.0 | % | ||||||||||
| Selling, general and administrative expenses | 3,830 | 15.7 | % | 3,084 | 18.0 | % | ||||||||||
| Loss from operations | (37 | ) | (0.1 | )% | (339 | ) | (2.0 | )% | ||||||||
| Other expense, net | (21 | ) | (0.1 | )% | (41 | ) | (0.2 | )% | ||||||||
| Loss before income taxes | (58 | ) | (0.2 | )% | (380 | ) | (2.2 | )% | ||||||||
| Benefit from income taxes | (14 | ) | (0.0 | )% | (79 | ) | (0.4 | )% | ||||||||
| Consolidated net loss | (44 | ) | (0.2 | )% | (301 | ) | (1.8 | )% | ||||||||
| Less: Net income attributable to noncontrolling interest | 3 | 0.0 | % | 4 | 0.0 | % | ||||||||||
| Net loss attributable to TSR, Inc. | $ | (47 | ) | (0.2 | )% | $ | (305 | ) | (1.8 | )% | ||||||
Page 17
TSR, INC. AND SUBSIDIARIES
Revenue
Revenue consists primarily of revenue from computer programming consulting services. Revenue for the quarter ended February 28, 2022 increased approximately $7,223,000 or 42.1% from the quarter ended February 28, 2021, primarily due to new business development, organic growth and expanded activity with Geneva clients. The average number of consultants on billing with customers increased from 486 for the quarter ended February 28, 2021 to 721 for the quarter ended February 28, 2022. There were 358 and 443 IT contractors at February 28, 2021 and 2022, respectively; while there were 128 and 278 clerical and administrative contractors at February 28, 2021 and 2022, respectively.
We experienced terminated assignments and a decrease in demand for new assignments during fiscal 2021 due to the COVID-19 pandemic, which led to the lower number of consultant placements during the year and negatively impacted the Company’s revenues. Additionally, the COVID-19 pandemic created operational challenges. The start of certain new assignments was delayed in the quarter ended February 28,2021 due to delays in obtaining necessary clearances, as many of the agencies required to be contacted in obtaining the information needed for background checks have been fully or partially closed. By the end of the first quarter of fiscal 2021, the Company had used 100% of the $6,659,000 proceeds from the PPP Loan (as defined in Note 12 to the Condensed Consolidated Unaudited Financial Statements elsewhere in this report) it received in April 2020 to fund its payroll and other allowable expenses, which was fully forgiven in July 2021. The use of these proceeds allowed the Company to avoid certain salary reductions, furloughs and layoffs of employees during the covered period.
Cost of Sales
Cost of sales for the quarter ended February 28, 2022 increased approximately $6,175,000 or 42.8% to $20,590,000 from $14,415,000 in the prior year period. The increase in cost of sales resulted primarily from an increase in consultants placed with customers, primarily from the new business development activity, organic growth and expanded activity with Geneva clients. Cost of sales as a percentage of revenue increased from 84.0% in the quarter ended February 28, 2021 to 84.4% in the quarter ended February 28, 2022. The percentage increase in cost of sales for the quarter ended February 28, 2022 as compared to the prior year period (42.8% increase) was higher than the percentage increase in revenue for the quarter ended February 28, 2022 as compared to the prior year period (42.1% increase), causing a decrease in gross margins percent.
Selling, General and Administrative Expenses
Selling, general and administrative expenses consist primarily of expenses relating to account executives, technical recruiters, facilities costs, management and corporate overhead. These expenses increased approximately $746,000 or 24.2% from $3,084,000 in the quarter ended February 28, 2021 to $3,830,000 in the quarter ended February 28, 2022. The increase in these expenses primarily resulted from an additional $465,000 in selling, general and administrative expenses for the Geneva accounts. The Company has invested in developing both on shore and offshore recruiting teams to support the potential of the Geneva accounts. The Company also has invested in expanding the on shore and offshore recruiting teams for the existing TSR accounts. Additionally, the Company incurred non-cash compensation expenses of $141,000 in the current quarter related to the Plan. Selling, general and administrative expenses, as a percentage of revenue decreased to 15.7% in the quarter ended February 28, 2022 from 18.0% in the quarter ended February 28, 2021.
Other Expense
Other expense for the quarter ended February 28, 2022 resulted primarily from net interest expense of approximately $20,000 and a mark-to-market loss of approximately $1,000 on the Company’s marketable equity securities. Other expense for the quarter ended February 28, 2021 resulted primarily from net interest expense of $51,000 and a mark-to-market gain of approximately $10,000 on the Company’s marketable equity securities. The decrease in interest expense is primarily attributed to the forgiveness of the PPP Loan principal and interest in July 2021.
Income Tax Benefit
The income tax benefit included in the Company’s results of operations for the quarters ended February 28, 2022 and 2021 reflect the Company’s estimated effective tax rate for the fiscal years ending May 31, 2022 and 2021, respectively. These rates resulted in a benefit of 24.1% for the quarter ended February 28, 2022 and a benefit of 20.8% for the quarter ended February 28, 2021. The difference between the rates is that for fiscal 2022 a full year profit is projected and in fiscal 2021 a taxable loss was projected and the expected tax benefit was reduced by certain non-deductible expenses.
Page 18
TSR, INC. AND SUBSIDIARIES
Net Loss Attributable to TSR
Net loss attributable to TSR was approximately $47,000 in the quarter ended February 28, 2022 compared to a net loss of $305,000 in the quarter ended February 28, 2021. The reduction in net loss in the current quarter was primarily attributable to the increase in revenue resulting from the increase in consultants on billing with customers.
Impact of Inflation and Changing Prices
For the quarters ended February 28, 2022 and 2021, inflation and changing prices did not have a material effect on the Company’s revenue or income from continuing operations.
Nine months ended February 28, 2022 compared with nine months ended February 28, 2021:
| (Dollar amounts in thousands) Nine Months Ended | ||||||||||||||||
| February 28, 2022 | February 28, 2021 | |||||||||||||||
| Amount | % of Revenue | Amount | % of Revenue | |||||||||||||
| Revenue, net | $ | 71,113 | 100.0 | % | $ | 47,743 | 100.0 | % | ||||||||
| Cost of sales | 59,462 | 83.6 | % | 39,831 | 83.4 | % | ||||||||||
| Gross profit | 11,651 | 16.4 | % | 7,912 | 16.6 | % | ||||||||||
| Selling, general and administrative expenses | 11,628 | 16.3 | % | 8,414 | 17.6 | % | ||||||||||
| Income (loss) from operations | 23 | 0.1 | % | (502 | ) | (1.0 | )% | |||||||||
| Other income (expense), net | 6,646 | 9.3 | % | (157 | ) | (0.3 | )% | |||||||||
| Income (loss) before income taxes | 6,669 | 9.4 | % | (659 | ) | (1.4 | )% | |||||||||
| Benefit from income taxes | (1 | ) | 0.0 | % | (114 | ) | 0.2 | % | ||||||||
| Consolidated net income (loss) | 6,670 | 9.4 | % | (545 | ) | (1.2 | )% | |||||||||
| Less: Net income attributable to noncontrolling interest | 72 | 0.1 | % | 10 | 0.0 | % | ||||||||||
| Net income (loss) attributable to TSR, Inc. | $ | 6,598 | 9.3 | % | $ | (555 | ) | (1.2 | )% | |||||||
Revenue
Revenue consists primarily of revenue from computer programming consulting services. Revenue for the nine months ended February 28, 2022 increased approximately $23,370,000 or 48.9% from the nine months ended February 28, 2021, primarily due to new business development, organic growth and expanded activity with Geneva clients. The average number of consultants on billing with customers increased from 443 for the nine months ended February 28, 2021 to 698 for the nine months ended February 28, 2022. There were 318 and 424 IT contractors at February 28, 2021 and 2022, respectively; while there were 125 and 274 clerical and administrative contractors at February 28, 2021 and 2022, respectively.
We experienced terminated assignments and a decrease in demand for new assignments during fiscal 2021 due to the COVID-19 pandemic, which led to the lower number of consultant placements during the year and negatively impacted the Company’s revenues. Additionally, the COVID-19 pandemic created operational challenges. The start of certain new assignments was delayed in the nine months ended February 28, 2021 due to delays in obtaining necessary clearances, as many of the agencies required to be contacted in obtaining the information needed for background checks have been fully or partially closed. By the end of the first quarter of fiscal 2021, the Company had used 100% of the $6,659,000 proceeds from the PPP Loan (as defined in Note 12 to the Condensed Consolidated Unaudited Financial Statements elsewhere in this report) it received in April 2020 to fund its payroll and other allowable expenses, which was fully forgiven in July 2021. The use of these proceeds allowed the Company to avoid certain salary reductions, furloughs and layoffs of employees during the covered period.
Page 19
TSR, INC. AND SUBSIDIARIES
Cost of Sales
Cost of sales for the nine months ended February 28, 2022 increased approximately $19,631,000 or 49.3% to $59,462,000 from $39,831,000 in the prior year period. The increase in cost of sales resulted primarily from an increase in consultants placed with customers, primarily from the new business development activity, organic growth and expanded activity with Geneva clients. Cost of sales as a percentage of revenue increased from 83.4% in the nine months ended February 28, 2021 to 83.6% in the nine months ended February 28, 2022. The percentage increase in cost of sales for the nine months ended February 28, 2022 as compared to the prior year period (49.3% increase) was higher than the percentage increase in revenue for the nine months ended February 28, 2022 as compared to the prior year period (48.9% increase), causing a decrease in gross margin percent.
Selling, General and Administrative Expenses
Selling, general and administrative expenses consist primarily of expenses relating to account executives, technical recruiters, facilities costs, management and corporate overhead. These expenses increased approximately $3,214,000 or 38.2% from $8,414,000 in the nine months ended February 28, 2021 to $11,628,000 in the nine months ended February 28, 2022. The increase in these expenses primarily resulted from an additional $1,884,000 in selling, general and administrative expenses for the Geneva accounts and a charge of $580,000 for the legal settlement with the former Chief Executive Officer. The Company has invested in developing both on shore and offshore recruiting teams to support the potential of the Geneva accounts. The Company has also invested in expanding the on shore and offshore recruiting teams for the existing TSR accounts. Additionally, the Company incurred non-cash compensation expenses of $496,000 in the current nine-month period related to the Plan. Selling, general and administrative expenses, as a percentage of revenue decreased to 16.3% in the nine months ended February 28, 2022 from 17.6% in the nine months ended February 28, 2021.
Other Income (Expense)
Other income for the nine months ended February 28, 2022 resulted primarily from the forgiveness of principal and interest on the PPP Loan of $6,735,000, offset by net interest expense of approximately $81,000 and a mark-to-market loss of approximately $8,000 on the Company’s marketable equity securities. Other expense for the nine months ended February 28, 2021 resulted primarily from net interest expense of $155,000 and a mark-to-market loss of approximately $2,000 on the Company’s marketable equity securities.
Income Tax Benefit
The income tax benefit included in the Company’s results of operations for the nine months ended February 28, 2022 and 2021 reflect the Company’s estimated effective tax rate for the fiscal years ending May 31, 2022 and 2021, respectively. These rates resulted in a benefit of less than 1% for the nine months ended February 28, 2022 and a benefit of 17.3% for the nine months ended February 28, 2021. The effective rate for the nine months ended February 28, 2022 is low because of the non-taxable gain on the forgiveness of the PPP Loan principal and accrued interest combined with low taxable income.
Net Income (Loss) Attributable to TSR
Net income attributable to TSR was approximately $6,598,000 in the nine months ended February 28, 2022 compared to a net loss of $555,000 in the nine months ended February 28, 2021. The net income in the current period was primarily attributable to the forgiveness of principal and accrued interest on the PPP Loan.
Impact of Inflation and Changing Prices
For the nine months ended February 28, 2022 and 2021, inflation and changing prices did not have a material effect on the Company’s revenue or income from continuing operations.
Liquidity and Capital Resources
The Company’s cash was sufficient to enable it to meet its liquidity requirements during the nine months ended February 28, 2022. The Company expects that its cash and cash equivalents and the Company’s Credit Facility pursuant to a Loan and Security Agreement with the Lender will be sufficient to provide the Company with adequate resources to meet its liquidity requirements for the 12-month period following the issuance of these financial statements. Utilizing its accounts receivable as collateral, the Company has secured this Credit Facility to increase its liquidity as necessary. As of February 28, 2022, the net borrowings outstanding against this Credit Facility were approximately $60,000. The amount the Company has borrowed fluctuates and, at times, it has utilized the maximum amount of $2,000,000 available under this facility to fund its payroll and other obligations. The Company was in compliance with all covenants under the Credit Facility as of February 28, 2022 and through the date of this filing. Additionally, in April 2020, the Company secured a PPP Loan in the amount of $6,659,000 to meet its obligations in the face of potential disruptions in its business operations and the potential inability of its customers to pay their accounts when due. As of August 31, 2020, the Company had used 100% of the PPP Loan funds to fund its payroll and for other allowable expenses under the PPP Loan. The use of these funds allowed the Company to avoid certain salary reductions, furloughs and layoffs of employees during the period. The Company applied for PPP Loan forgiveness and its application for forgiveness was accepted and approved; the PPP Loan and accrued interest were fully forgiven in July 2021.
Page 20
TSR, INC. AND SUBSIDIARIES
At February 28, 2022, the Company had working capital (total current assets in excess of total current liabilities) of approximately $10,642,000, including cash and cash equivalents and marketable securities of $6,524,000 as compared to working capital of $8,898,000, including cash and cash equivalents and marketable securities of $7,416,000 at May 31, 2021.
Net cash flow of approximately $2,472,000 was used in operations during the nine months ended February 28, 2022 as compared to $510,000 of net cash provided by operations in the prior year period. The cash used in operations for the nine months ended February 28, 2022 primarily resulted from consolidated net income of $6,670,000, offset by the forgiveness of the PPP Loan principal and accrued interest of $6,735,000, an increase in accounts receivable of $2,758,000 and a decrease in legal settlement payable of $277,000. The cash provided operations for the nine months ended February 28, 2021 primarily resulted from an increase in accounts payable and accrued expenses of $2,121,000, offset by the consolidated loss of $555,000 and increases in accounts receivable and prepaid expenses of $1,037,000 and $143,000, respectively.
Net cash used in investing activities of approximately $81,000 for the nine months ended February 28, 2022 primarily resulted from purchases of fixed assets. Net cash used in investing activities of $3,133,000 for the nine months ended February 28, 2021 primarily resulted from the acquisition of Geneva in the amount of $3,100,000.
Net cash provided by financing activities of approximately $1,669,000 during the nine months ended February 28, 2022 resulted from the net proceeds from the sales of the Company’s common stock in our ATM program of $1,821,000 offset by payments made for taxes related to vested stock awards of $92,000, net payments on the Company’s Credit Facility of $33,000 and distributions to the minority interest of $27,000. Net cash used in financing activities during the nine months ended February 28, 2021 of $473,000 primarily resulted from net repayments under the Company’s Credit Facility.
The Company’s capital resource commitments at February 28, 2022 consisted of lease obligations on its branch and corporate facilities and an accrued legal settlement payable. The net present value of its future lease and settlement payments were approximately $787,000 and $590,000, respectively, as of February 28, 2022. The Company intends to finance these commitments primarily from the Company’s available cash and Credit Facility.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Critical Accounting Estimates
The Securities Act regulations define “critical accounting estimates” as those estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on the financial condition or results of operations of the registrant. These estimates require the application of management’s most difficult subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.
The Company’s significant accounting estimates and policies are described in Note 1 to the Company’s consolidated financial statements, contained in its May 31, 2021 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission. The Company believes that those accounting policies require the application of management’s most difficult, subjective or complex judgments. There have been no changes in the Company’s significant accounting policies as of February 28, 2022.
Page 21
TSR, INC. AND SUBSIDIARIES
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
As a smaller reporting company, we are not required to provide the information called for by this Item.
Item 4. Controls and Procedures
Disclosure Controls and Procedures. The Company conducted an evaluation, under the supervision and with the participation of the principal executive officer and principal accounting officer, of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934). Based on this evaluation, the principal executive officer and principal accounting officer concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures are effective.
Internal Control Over Financial Reporting. There was no change in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Page 22
TSR, INC. AND SUBSIDIARIES
Part II. Other Information
Item 1. Legal Proceedings
Christopher Hughes v. TSR, Inc., Docket No. 651753-2020 (NY Supr. Ct., New York County)
Christopher Hughes, the former Chief Executive Officer of the Company (“Plaintiff”), filed a complaint against the Company in the Supreme Court of the State of New York in March 2020 alleging two causes of action: (1) breach of his employment contract; and (2) breach of duty of good faith and fair dealing. Plaintiff alleges that he was terminated without cause or in the alternative that he resigned for reason and therefore, pursuant to the Amended and Restated Employment Agreement, dated August 9, 2018, between the Company and Plaintiff, Plaintiff seeks severance pay in the amount of $1,000,000 and reasonable costs and attorney’s fees. The Company denies Plaintiff’s allegations in their entirety and has filed counterclaims against Plaintiff for (1) declaratory relief; (2) breach of confidence/non-compete agreement; (3) declaratory and injunctive relief – confidence/non-compete; (4) tortious interference with current and prospective contractual and economic relations; (5) breach of fiduciary duty; (6) misappropriation of trade secrets; (7) declaratory and injunctive relief – unfair competition; and (8) conversion.
In October 2021, the Company and Hughes agreed through mediation to settle this matter. In order to avoid lengthy and costly litigation and discovery expenses, the Company has paid Hughes $705,000 to settle all claims. After adjusting for estimated expected insurance reimbursement, the Company accrued a charge of $580,000 to selling, general and administrative expenses in the quarter ended August 31, 2021.
Fintech Consulting LLC v. TSR, Inc., et al., case number 2:21-cv-20181(KSH)(AME) (U.S. Dist. Ct., Dist. of New Jersey)
On December 1, 2021, Fintech Consulting LLC filed a complaint against the Company in the United States District Court for the District of New Jersey. The named Defendants in the complaint are the Company, QAR Industries, Inc., a shareholder of TSR (“QAR”), Robert E. Fitzgerald, a director and shareholder of TSR and the President, director and a shareholder of QAR (“Fitzgerald”), and Bradley Tirpak, a shareholder and the chairman of the board of directors of TSR (“Tirpak”). The complaint purports to assert claims against the Defendants under state law and Section 10(b) of the Exchange Act in connection with a Share Purchase Agreement, dated January 31, 2021, by and between the Plaintiff, as the seller of shares of TSR’s common stock, and QAR and Tirpak, as the purchasers of such shares (the “SPA”). The plaintiff seeks (i) judgment declaring the transactions represented by the SPA null and avoid and returning the shares; (ii) judgment cancelling the SPA and returning the shares in exchange for return of the purchase price; (iii) judgement unwinding the transaction; (iv) compensatory damages; (v) punitive damages; (vi) pre-judgment interest; (vii) costs of suit including attorneys’ fees; and (viii) such other relief as the Court may find appropriate. See Note 16 to the Condensed Consolidated Unaudited Financial Statements elsewhere in this report and the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2021 for more information.
The Company believes the action described above to be without merit and intends to vigorously defend its interests. However, the Company may incur significant additional legal expenses as it pursues a vigorous defense against this action.
While the Company believes the action to be without merit, no assurances can be given as to: (i) the outcome of this or other legal proceedings and (ii) the related impact of an unanticipated adverse outcome of these proceedings on the Company’s financial condition, results of operations or near-term liquidity.
Page 23
TSR, INC. AND SUBSIDIARIES
Item 1A. Risk Factors
We operate in a rapidly changing environment that involves a number of risks that could materially affect our business, financial condition or future results, some of which are beyond our control. In addition to the other information set forth in this Quarterly Report on Form 10-Q and the risk factors included below, you should carefully consider the factors in Part I, “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended May 31, 2021, as filed with the Securities and Exchange Commission.
We completed the acquisition of Geneva Consulting Group, Inc. (“Geneva”) and may conduct additional acquisitions in the future. Due to the risks and uncertainties related to the acquisition of new businesses, any such acquisitions do not guarantee that we will be able to attain or maintain profitability.
On September 1, 2020, we completed the acquisition of all of the outstanding stock of Geneva, a provider of temporary and permanent information technology personnel based in Port Washington, New York, which we believe will help diversify our business and expand the scope of our services. As part of a potential growth strategy, we may attempt to acquire or merge with certain businesses. Whether we realize the potential benefits from any such transactions, including the acquisition of Geneva, will depend in part upon the integration of the acquired businesses, the performance of the acquired assets and services, and the personnel hired in connection therewith. Accordingly, our results of operations could be adversely impacted by transaction-related costs, amortization of intangible assets, and charges for impairment of long-term assets. While we believe that we have established appropriate and adequate procedures and processes to mitigate these risks, there can be no assurance that any potential transaction will be successful.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3. Defaults upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
Page 24
TSR, INC. AND SUBSIDIARIES
Item 6. Exhibits
| Exhibit | Document | |
| Exhibit 31.1 | Rule 13a-14(a)/15d-14(a) Certification by Thomas Salerno as principal executive officer | |
| Exhibit 31.2 | Rule 13a-14(a)/15d-14(a) Certification by John G. Sharkey as principal financial officer | |
| Exhibit 32.1 | Section 1350 Certification by Thomas Salerno as principal executive officer | |
| Exhibit 32.2 | Section 1350 Certification by John G. Sharkey as principal financial officer | |
| Exhibit 101 | Interactive Data File containing the following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2022, formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) the Notes to the Condensed Consolidated Financial Statements. | |
| Exhibit 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Page 25
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.
| TSR, Inc. | |
| (Registrant) |
| Date: April 11, 2022 | /s/ Thomas Salerno |
| Thomas Salerno, Chief Executive Officer, President, Treasurer and Principal Executive Officer | |
| Date: April 11, 2022 | /s/ John G. Sharkey |
| John G. Sharkey, Sr. Vice President, Chief Financial Officer, Secretary, Principal Financial Officer and Principal Accounting Officer |
Page 26
Exhibit 31.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Thomas Salerno, Chief Executive Officer, President, Treasurer and Principal Executive Officer certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of TSR, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| d. | Disclosed in this report any change in registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: April 11, 2022 | |
| /s/ Thomas Salerno | |
| Chief Executive Officer, President, Treasurer and Principal Executive Officer |
Exhibit 31.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John G. Sharkey, Sr. Vice President, Chief Financial Officer and Principal Accounting Officer, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of TSR, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d. | Disclosed in this report any change in registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: April 11, 2022 | |
| /s/ John G. Sharkey | |
| Sr. Vice President, Chief Financial Officer, Secretary, Principal Financial Officer and Principal Accounting Officer |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of TSR, Inc. (the “Company”) on Form 10-Q for the quarter ended February 28, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas Salerno, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
The foregoing certification is incorporated solely for the purposes of complying with the provisions of Section 906 of the Sarbanes-Oxley Act and is not intended to be used for any other purpose.
| /s/ Thomas Salerno | |
| Chief Executive Officer, President, Treasurer and Principal Executive Officer | |
| April 11, 2022 |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of TSR, Inc. (the “Company”) on Form 10-Q for the quarter ended February 28, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John G. Sharkey, Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
The foregoing certification is incorporated solely for the purposes of complying with the provisions of Section 906 of the Sarbanes-Oxley Act and is not intended to be used for any other purpose.
| /s/ John G. Sharkey | |
| Sr. Vice President, Chief Financial Officer, Secretary, Principal Financial Officer and Principal Accounting Officer | |
| April 11, 2022 |
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) |
Feb. 28, 2022 |
May 31, 2021 |
|---|---|---|
| Statement of Financial Position [Abstract] | ||
| Allowance for doubtful accounts related to accounts receivable (in Dollars) | $ 181,000 | $ 181,000 |
| Net of accumulated depreciation and amortization (in Dollars) | $ 172,973 | $ 155,006 |
| Preferred stock par value (in Dollars per share) | $ 1 | $ 1 |
| Preferred stock, shares authorized | 500,000 | 500,000 |
| Preferred stock, shares issued | ||
| Common stock par value (in Dollars per share) | $ 0.01 | $ 0.01 |
| Common stock, shares authorized | 12,500,000 | 12,500,000 |
| Common stock, shares issued | 3,114,163 | 3,114,163 |
| Common stock, shares outstanding | 1,962,062 | 1,962,062 |
| Treasury stock, shares | 1,152,101 | 1,152,101 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Feb. 28, 2022 |
Feb. 28, 2021 |
Feb. 28, 2022 |
Feb. 28, 2021 |
|
| Income Statement [Abstract] | ||||
| Revenue, net | $ 24,383,217 | $ 17,160,494 | $ 71,112,784 | $ 47,743,077 |
| Cost of sales | 20,590,154 | 14,414,611 | 59,461,322 | 39,831,025 |
| Selling, general and administrative expenses | 3,829,819 | 3,084,495 | 11,628,284 | 8,414,414 |
| Cost and expenses, total | 24,419,973 | 17,499,106 | 71,089,606 | 48,245,439 |
| Income (loss) from operations | (36,756) | (338,612) | 23,178 | (502,362) |
| Other income (expense): | ||||
| Interest expense, net | (19,526) | (51,297) | (81,510) | (155,270) |
| Gain on PPP Loan and interest forgiveness | 6,735,246 | |||
| Unrealized gain (loss) on marketable securities, net | (1,200) | 9,944 | (7,536) | (1,720) |
| Income (loss) before income taxes | (57,482) | (379,965) | 6,669,378 | (659,352) |
| Benefit from income taxes | (14,000) | (79,000) | (1,000) | (114,000) |
| Consolidated net income (loss) | (43,482) | (300,965) | 6,670,378 | (545,352) |
| Less: Net income attributable to noncontrolling interest | 3,129 | 3,964 | 72,410 | 9,335 |
| Net income (loss) attributable to TSR, Inc. | $ (46,611) | $ (304,929) | $ 6,597,968 | $ (554,687) |
| Basic net income (loss) per TSR, Inc. common share (in Dollars per share) | $ (0.02) | $ (0.16) | $ 3.33 | $ (0.28) |
| Diluted net income (loss) per TSR, Inc. common share (in Dollars per share) | $ (0.02) | $ (0.16) | $ 3.19 | $ (0.28) |
| Basic weighted average number of common shares outstanding (in Shares) | 2,027,494 | 1,962,062 | 1,983,146 | 1,962,062 |
| Diluted weighted average number of common shares outstanding (in Shares) | 2,027,494 | 1,962,062 | 2,066,976 | 1,962,062 |
Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals) - USD ($) |
9 Months Ended | |
|---|---|---|
Feb. 28, 2022 |
Feb. 28, 2021 |
|
| Statement of Cash Flows [Abstract] | ||
| Net of cash acquired | $ 241,946 | $ 241,946 |
Basis of Presentation |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Accounting Policies [Abstract] | ||||
| Basis of Presentation |
The accompanying condensed consolidated interim financial statements include the accounts of TSR, Inc. and its subsidiaries. Unless otherwise stated or the context otherwise requires, the terms “we,” “us,” “our,” and the “Company” refer to TSR, Inc. and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. The condensed balance sheet as of May 31, 2021, which has been derived from audited financial statements, and the unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applying to interim financial information and with the instructions to Form 10-Q of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures required by accounting principles generally accepted in the United States of America and normally included in the Company’s annual financial statements have been condensed or omitted. These condensed consolidated interim financial statements as of and for the three months and nine months ended February 28, 2022 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring adjustments) necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. The results of operations for the interim periods presented are not necessarily indicative of the results that might be expected for future interim periods or for the full year ending May 31, 2022. These condensed consolidated interim financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended May 31, 2021. |
Net Income (Loss) Per Common Share |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Earnings Per Share [Abstract] | ||||
| Net Income (Loss) Per Common Share |
Basic net income (loss) per common share is computed by dividing net income (loss) available to common stockholders of TSR by the weighted average number of common shares outstanding during the reporting period, excluding the effects of any potentially dilutive securities. During the quarter ended February 28, 2021, the Company granted time and performance vesting restricted stock awards under its 2020 Equity Incentive Plan (see Note 17 for further information). Diluted earnings per share gives effect to all potentially dilutive common shares outstanding during the reporting period. The common stock equivalents associated with these restricted stock awards of 84,293 and 83,830 in the three months and nine months ended February 28, 2022 have only been included for dilutive shares outstanding for the nine months ended February 28, 2022 since there was a loss for the three month period ended February 28, 2022. |
Cash and Cash Equivalents |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents |
The Company considers short-term highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. Cash and cash equivalents were comprised of the following as of February 28, 2022 and May 31, 2021:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments |
9 Months Ended | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||
| Fair Value of Financial Instruments [Abstract] | ||||||||||||||||||||||||||||
| Fair Value of Financial Instruments |
Accounting Standards Codification (“ASC”) 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”), defines fair value, establishes a framework for measuring fair value under accounting principles generally accepted in the United States of America (“GAAP”) and provides for expanded disclosure about fair value measurements. ASC 820-10 applies to all other accounting pronouncements that require or permit fair value measurements. The Company determines or calculates the fair value of financial instruments using quoted market prices in active markets when such information is available or using appropriate present value or other valuation techniques, such as discounted cash flow analyses, incorporating available market discount rate information for similar types of instruments while estimating for non-performance and liquidity risk. These techniques are significantly affected by the assumptions used, including the discount rate, credit spreads and estimates of future cash flows.
Assets and liabilities typically recorded at fair value on a non-recurring basis to which ASC 820-10 applies include:
This topic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and establishes a three-level hierarchy, which encourages an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820-10 requires that assets and liabilities recorded at fair value be classified and disclosed in one of the following three categories:
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company classifies such financial assets or liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
ASC Topic 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. For cash and cash equivalents, accounts receivable, accounts and other payables, accrued liabilities and advances from customers, the amounts presented in the condensed consolidated financial statements approximate fair value because of the short-term maturities of these instruments. |
Marketable Securities |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments, Debt and Equity Securities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Marketable Securities |
The Company has characterized its investments in marketable securities, based on the priority of the inputs used to value the investments, into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and lowest priority to unobservable inputs (Level 3). If the inputs used to measure the investments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
Investments recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs to valuation techniques as follows:
The following are the major categories of assets measured at fair value on a recurring basis as of February 28, 2022 and May 31, 2021 using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2) and significant unobservable inputs (Level 3):
The Company’s equity securities are classified as trading securities, which are carried at fair value, as determined by quoted market prices, which is a Level 1 input, as established by the fair value hierarchy. The related unrealized gains and losses are included in earnings. The Company’s marketable securities at February 28, 2022 and May 31, 2021 are summarized as follows:
The Company’s investments in marketable securities consist primarily of investments in equity securities. Market values were determined for each individual security in the investment portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, and the Company’s ability and intent to hold the investment for a period of time, which may be sufficient for anticipated recovery in market values. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Matters |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Disclosure of Other Matters [Abstract] | ||||
| Other Matters |
From time to time, the Company is party to various lawsuits, some involving material amounts. Management is not aware of any lawsuits that would have a material adverse impact on the consolidated financial position of the Company except for the litigation disclosed elsewhere in the report, including Notes 9, 10, 16 and 19 to the Condensed Consolidated Financial Statements and in the section titled “Item 1, Legal Proceedings” in Part II of this report. |
Leases |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases |
The Company leases the space for its three offices in New York City, Hauppauge and New Jersey. Under ASC 842, at contract inception we determine whether the contract is or contains a lease and whether the lease should be classified as an operating or finance lease. Operating leases are in right-of-use assets and operating lease liabilities are in our condensed consolidated balance sheets.
The Company’s leases for its three offices are classified as operating leases.
The lease agreements for New York City, Hauppauge and New Jersey expire on August 31, 2022, December 31, 2023 and May 31, 2027, respectively, and do not include any renewal options. During the fiscal year ended May 31, 2021, the Company extended its lease in Hauppauge, entered into a lease in a new location for its New Jersey office expiring May 31, 2027 and entered into an agreement to sublease the space in New York City expiring August 31, 2022. Due to the fact that the future sublease cash inflows will be less than the carrying value of the corresponding right-of-use asset, the Company recorded a right-of-use asset impairment charge of $136,599 in the quarter ended November 30, 2020.
In addition to the monthly base amounts in the lease agreements, the Company is required to pay real estate taxes and operating expenses during the lease terms.
For the nine months ended February 28, 2022 and 2021, the Company’s operating lease expense for these leases was $240,000 and $352,000, respectively.
Future minimum lease payments under non-cancellable operating leases as of February 28, 2022 were as follows:
The following table sets forth the right-of-use assets and operating lease liabilities as of February 28, 2022:
The weighted average remaining lease term for the Company’s operating leases is 2.9 years. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit Facility |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Credit Facility [Abstract] | ||||
| Credit Facility |
On November 27, 2019, TSR closed on a revolving credit facility (the “Credit Facility”) pursuant to a Loan and Security Agreement with Access Capital, Inc. (the “Lender”) that initially provided up to $7,000,000 in funding to TSR and its direct and indirect subsidiaries, TSR Consulting Services, Inc., Logixtech Solutions, LLC and Eurologix, S.A.R.L., each of which, together with TSR, is a borrower under the Credit Facility. Each of the borrowers has provided a security interest to the Lender in all of their respective assets to secure amounts borrowed under the Credit Facility.
TSR expects to utilize the Credit Facility for working capital and general corporate purposes. The maximum amount that may now be advanced under the Credit Facility at any time shall not exceed $2,000,000.
Advances under the Credit Facility accrue interest at a rate per annum equal to (x) the “base rate” or “prime rate” announced by Citibank, N.A. from time to time, which shall be increased or decreased, as the case may be, in an amount equal to each increase or decrease in such “base rate” or “prime rate,” plus (y) 1.75%. The prime rate as of February 28, 2022 was 3.25%, indicating an interest rate of 5.0% on the line of credit. The initial term of the Credit Facility is five years, which shall automatically renew for successive five-year periods unless either TSR or the Lender gives written notice to the other of termination at least 60 days prior to the expiration date of the then-current term.
TSR is obliged to satisfy certain financial covenants and minimum borrowing requirements under the Credit Facility, and to pay certain fees, including prepayment fees, and provide certain financial information to the Lender. The Company was in compliance with all applicable covenants at February 28, 2022.
As of February 28, 2022, the net borrowings outstanding against this line of credit facility were $60,000. The amount the Company has borrowed fluctuates and, at times, it has utilized the maximum amount of $2,000,000 available under the facility to fund its payroll and other obligations. |
Termination of Former CEO |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Termination of Former CEO [Abstract] | ||||
| Termination of Former CEO |
The Company terminated Christopher Hughes, the former Chief Executive Officer of the Company (“Hughes”), effective February 29, 2020 for “Cause” as defined in Section 6(a) of his Amended and Restated Employment Agreement dated August 9, 2018 (the “Employment Agreement”). Despite having already been terminated from employment, on March 2, 2020, the Company received a letter from Mr. Hughes, providing notice of his intent to resign for “Good Reason” as defined in Section 7(c) of the Employment Agreement pursuant to which he claimed to be entitled to the “Enhanced Severance Amount” under the Employment Agreement. Hughes filed a complaint against the Company in the Supreme Court of the State of New York in March 2020 alleging two causes of action: (1) breach of his employment contract; and (2) breach of duty of good faith and fair dealing. Plaintiff Hughes alleged that he was terminated without cause or in the alternative that he resigned for good reason and therefore, pursuant to the Employment Agreement, Hughes sought severance pay in the amount of $1,000,000 and reasonable costs and attorney’s fees. The Company denied Plaintiff’s allegations in their entirety and filed counterclaims against Plaintiff for (1) declaratory relief; (2) breach of confidence/non-compete agreement; (3) declaratory and injunctive relief – confidence/non-compete; (4) tortious interference with current and prospective contractual and economic relations; (5) breach of fiduciary duty; (6) misappropriation of trade secrets; (7) declaratory and injunctive relief – unfair competition; and (8) conversion.
In October 2021, the Company and Hughes agreed through mediation to settle this matter. In order to avoid lengthy and costly litigation and discovery expenses, the Company has paid Hughes $705,000 to settle all claims. After adjusting for insurance reimbursement, the Company accrued a charge of $580,000 to selling, general and administrative expenses in the quarter ended August 31, 2021 and nine months ended February 28, 2022. |
Legal Settlement with Investor |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Legal Settlement with Investor [Abstract] | ||||
| Legal Settlement with Investor |
On April 1, 2020, the Company entered into a binding term sheet (“Term Sheet”) with Zeff Capital, L.P. (“Zeff”) pursuant to which it agreed to pay Zeff an amount of $900,000 over a period of three years in cash or cash and stock in settlement of expenses incurred by Zeff during its solicitations in 2018 and 2019 in connection with the annual meetings of the Company, the costs incurred in connection with the litigation initiated by and against the Company as well as negotiation, execution and enforcement of the Settlement and Release Agreement, dated as of August 30, 2019, by and between the Company, Zeff and certain other parties. In exchange for certain releases, the Term Sheet calls for a cash payment of $300,000 on June 30, 2021, a second cash payment of $300,000 on June 30, 2022 and a third payment of $300,000 also on June 30, 2022, which can be paid in cash or common stock at the Company’s option. There is no interest due on these payments. The $300,000 payment due June 30, 2021 was paid during the quarter ended August 31, 2021. The agreement also has protections to defer such payment dates so that the debt covenants with the Company’s lender are not breached. On August 13, 2020, the Company, Zeff, Zeff Holding Company, LLC and Daniel Zeff entered into a settlement agreement to reflect these terms. Any installment payment which is deferred as permitted above will accrue interest at the prime rate plus 3.75%, and Zeff shall thereby have the option to convert such deferred amounts (plus accrued interest if any) into shares of the Company’s stock. The Company accrued $818,000, the estimated present value of these payments using an effective interest rate of 5%, in the quarter ended February 29, 2020, as the events relating to the expense occurred prior to such date. The estimated present value of the remaining payments is $590,000 at February 28, 2022. |
COVID-19 |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Covid Nineteen [Abstract] | ||||
| COVID-19 |
The COVID-19 outbreak in the United States has caused business disruption including mandated and voluntary closing of various businesses. While the disruption is currently expected to be temporary, there is considerable uncertainty around the duration of the closings and the impact of the pandemic on our business. Therefore, the Company expects this matter to continue to negatively impact its operating results in future periods. The full financial impact and duration cannot be reasonably estimated at this time. |
Paycheck Protection Program Loan |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Payroll Protection Program Loan [Abstract] | ||||
| Paycheck Protection Program Loan |
On April 15, 2020, the Company received loan proceeds of $6,659,220 under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (“PPP”) was established under the congressionally-approved Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). The PPP Loan to the Company was made through JPMorgan Chase Bank, N.A., a national banking association.
In March 2021, the Company submitted a PPP Loan Forgiveness application to the SBA through the PPP Lender. On July 7, 2021, the Company received notification from the PPP Lender that the SBA approved the Company’s application for forgiveness of the entire principal amount of the PPP Loan plus accrued interest. The PPP Lender will apply the forgiveness amount to satisfy the PPP Loan. The Company has no further obligations with respect to the PPP Loan. The Company recognized “Other Income” of $6,735,246 in the quarter ended August 31, 2021 and nine months ended February 28, 2022 related to the forgiveness of the loan principal and accrued interest. |
Geneva Consulting Group Acquisition |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Combinations [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Geneva Consulting Group Acquisition |
On September 1, 2020, the Company completed the acquisition of all of the outstanding stock of Geneva Consulting Group, Inc., a New York corporation (“Geneva”) and provider of temporary and permanent information technology personnel based in Port Washington, New York. The stock of Geneva was purchased from the three shareholders of Geneva (the “Sellers”), none of which had, or will have following the acquisition, a material relationship with the Company or its affiliates.
The purchase price for the shares of Geneva was comprised of the following: (i) $1,452,000 in cash paid to Sellers at the closing of the acquisition, (ii) an amount of $748,000, which was equal to the amount of Geneva’s loan under the PPP that was not assumed by the Company and was substantially forgiven by the SBA, (iii) an amount up to $300,000, originally payable paid as an earnout payment in part in February 2021 and in part in August 2021 (the “Earnout Payments”), (iv) bonus payments payable in $10,000 increments, (v) $747,000 for the net working capital of Geneva as of closing and (vi) other purchase price adjustments of which $36,000 has been paid to date. Any Earnout Payments and bonus payments were to be determined based upon the achievement of certain criteria relating to the number the Company’s contractors working full-time at the Company’s client locations on such dates.
The initial Earnout Payments and bonus payment liability was valued at its fair value using an option pricing based approach with a risk-neutral framework using Black Scholes due to the option-like nature of the earnout payment structure (Level 3 of the fair value hierarchy). The Earnout Payments were revalued quarterly prior to the resolution discussed below, using a present value approach and any resulting increase or decrease was recorded into selling, general and administrative expenses. Any changes in the amount of the actual results and forecasted scenarios could impact the fair value. Significant judgment was employed in determining the appropriateness of the assumptions used in calculating the fair value of the Earnout Payments as of the acquisition date and subsequent period ends.
On March 17, 2021, the Company entered into an agreement with the Sellers’ representatives pursuant to which the parties agreed to resolve certain interpretive differences regarding the Sellers’ entitlement to the bonus payments described above. Pursuant to this agreement, and in full satisfaction of the Company’s obligations for deferred payments under the purchase agreement for the Geneva acquisition, the Sellers’ representative acknowledged receipt of the first Earnout Payment in the amount of $100,000, the parties agreed that the Company would make aggregate bonus payments to the Sellers’ representatives in the amount of $260,000, and the Company agreed to instruct the escrow agent to release to the Sellers’ representatives the second Earnout Payment in the amount of $200,000. All amounts relating to the Earnout Payments and bonus payments that had not been paid as of the date of the agreement were either paid by the Company or released by the escrow agent on March 18, 2021. This agreement resulted in a charge to selling, general and administrative expenses of $210,000 in the quarter ended February 28, 2021. No further earnout or bonus amounts can be earned or will be paid subsequent to March 18, 2021.
The acquisition was accounted for as an acquisition of a business in accordance with the acquisition method of accounting. The acquired assets and assumed liabilities were recorded at their fair values. The Company determined the fair values with the assistance of valuations performed by an independent third-party specialist.
The Company incurred approximately $498,000 in legal fees, business broker fees, valuation services, accounting fees and other expenses to complete the Geneva acquisition. Included in this amount is additional bonus payments to the Sellers of $210,000 related to the March 17, 2021 agreement discussed above. All acquisition related costs have been expensed as incurred and included in selling, general and administrative expenses for the nine months ended February 28, 2021.
The following table summarizes the components of the purchase price at fair values at September 1, 2020:
The following table summarizes the allocation of purchase price at estimated fair values at September 1, 2020:
The following unaudited pro forma financial information presents the combined operating results of the Company and Geneva as if the acquisition had occurred as of the beginning of the earliest period presented. Pro forma data is subject to various assumptions and estimates and is presented for informational purposes only. This pro forma data does not purport to represent or be indicative of the consolidated operating results that would have been reported had the transaction been completed as described herein, and the data should not be taken as indicative of future operating results.
Unaudited pro forma financial information assuming the acquisition of Geneva as of June 1, 2020 is presented in the following table (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Goodwill [Abstract] | ||||
| Goodwill |
Goodwill is recorded when the purchase price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Goodwill is not amortized but is subject to impairment analysis at least once annually or more frequently upon the occurrence of an event or when circumstances indicate that the carrying amount of a unit is greater than its fair value. The annual test of goodwill was performed as of September 1, 2021 and no impairment was found. |
Intangible Assets |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intangible Assets |
The Company amortizes its intangible assets over their estimated useful lives and will review these assets for impairment when there is evidence that events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If intangible assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.
Intangible assets are as follows:
No instances of triggering events or impairment indicators were identified at February 28, 2022. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Related Party Transactions [Abstract] | ||||
| Related Party Transactions |
On January 5, 2021, the members of the Board of Directors of the Company other than Robert Fitzgerald approved providing a waiver to QAR Industries, Inc. for its contemplated acquisition of shares owned by Fintech Consulting LLC under the Company’s then existing rights agreement (which covered a now non-existent class of Class A preferred stock) so that a distribution date would not occur under such agreement as a result of the acquisition. QAR Industries, Inc. and Fintech Consulting LLC were both principal stockholders of the Company, each owning more than 5% of the Company’s outstanding common stock prior to the consummation of the acquisition. Robert Fitzgerald is the President and majority shareholder of QAR Industries, Inc. The other directors of the Company are not affiliated with QAR Industries, Inc.
On February 3, 2021, the transaction was completed and QAR Industries, Inc. purchased 348,414 shares of TSR’s common stock from Fintech Consulting LLC at a price of $7.25 per share. At the same time, Bradley M. Tirpak, Chairman of TSR purchased 27,586 shares of TSR’s common stock from Fintech Consulting LLC at a price of $7.25 per share. The foregoing transaction is currently the subject of litigation due to a complaint filed by Fintech Consulting LLC on December 1, 2021. For more information about the foregoing complaint and litigation, please see Note 19 to the Condensed Consolidated Financial Statements and, section titled “Item 1, Legal Proceedings” in Part II of this report and the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2021. |
Stock-Based Compensation Expense |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Share-Based Payment Arrangement [Abstract] | ||||
| Stock-based Compensation Expense |
On January 28, 2021, the Company granted 108,333 shares in time vesting restricted stock awards and 69,167 shares in time and performance vesting restricted stock awards to officers, directors and key employees under the TSR, Inc. 2020 Equity Incentive Plan (the “Plan”). The time vesting shares vest in tranches at the one, two and three-year anniversaries of the grants (“service condition”). These shares had a grant date fair value of $826,000 based on the closing price of TSR’s common stock on the day prior to the grants. The associated compensation expense is recognized on a straight-line basis over the time between grant date and the date the shares vest (the “service period”). The time and performance vesting shares also vest in tranches at or after the two- and three-year anniversaries of the grants. The performance condition is defined in the grant agreements and relates to the market price of the Company’s common stock over a stated period of time (“market condition”). These shares had a grant date value of $262,000 based on the closing price of TSR common shares on the day prior to the grants discounted by an estimated forfeiture rate of 40-60%. The Company took into account the historical volatility of its common stock to assess the probability of satisfying the market condition. The associated compensation expense is recognized on a straight-line basis between the time the achievement of the performance criteria is deemed probable and the time the shares may vest. The market condition for the shares that vest on the two-year anniversary was met in October 2021. During the three and nine months ended February 28, 2022, $141,000 and $496,000, respectively, has been record as stock-based compensation expense and included in selling, general and administrative expenses. As of February 28, 2022, there is approximately $356,000 of unearned compensation expense that will be expensed through February 2024; 142,666 stock awards expected to vest; 56,666 awards vested to date, of which 14,780 were forfeited to pay taxes applicable to the stock awards. |
Common Stock |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Stockholders' Equity Note [Abstract] | ||||
| Common Stock |
Our certificate of incorporation, as amended, authorizes the issuance of up to 12,500,000 shares of common stock, $0.01 par value per share.
On October 8, 2021, the Company filed an automatic shelf registration statement on Form S-3 (File No. 333-260152) (the “2021 TSRI Shelf”) which contains (i) a base prospectus, which covers the offering, issuance and sale by the Company of up to $5,000,000 in the aggregate of shares of common stock from time to time in one or more offerings; and (ii) a sales agreement prospectus, which covers the offering, issuance and sale by the Company of up to $4,167,000 in the aggregate of shares of common stock that may be issued and sold from time to time under an at-the-market sales agreement (the “2021 ATM”) by and between the Company and A.G.P./Alliance Global Partners, as sales agent (the “2021 Agent”). The $4,167,000 of common stock that may be offered, issued and sold under the sales agreement prospectus is included in the $5,000,000 of shares of common stock that may be offered, issued and sold by the Company under the base prospectus. Upon termination of the sales agreement, any portion of the $4,167,000 included in the sales agreement prospectus that is not sold pursuant to the sales agreement will be available for sale in other offerings pursuant to the base prospectus and if no shares are sold under the agreement, the full $4,167,000 of securities may be sold in other offerings pursuant to the base prospectus. Under the 2021 ATM, we pay the 2021 Agent a commission rate equal to 3.0% of the gross sales price per share of all shares sold through the 2021 Agent under the sales agreement.
During the three months and nine months ended February 28, 2022, we sold an aggregate of 142,500 shares of common stock pursuant to the 2021 ATM for total gross proceeds of $1,965,623 at an average selling price of $13.79 per share, resulting in net proceeds of approximately $1,821,090 after deducting $144,533 in commissions and other transactions costs.
The 2021 TSRI Shelf is currently our only active shelf-registration statement. We may offer TSR common stock registered under the 2021 TSRI Shelf from time to time in response to market conditions or other circumstances if we believe such a plan of financing is in the best interests of our stockholders. We believe that the 2021 TSRI Shelf provides us with the flexibility to raise additional capital to finance our operations as needed. However, there is no assurance we will be successful in doing so. |
Pending Legal Issue |
9 Months Ended | |||
|---|---|---|---|---|
Feb. 28, 2022 | ||||
| Pending Legal Issue [Abstract] | ||||
| Pending Legal Issue |
On December 1, 2021, Fintech Consulting LLC filed a complaint against the Company in the United States District Court for the District of New Jersey. The named Defendants in the complaint are the Company, QAR Industries, Inc., a shareholder of TSR (“QAR”), Robert E. Fitzgerald, a director and shareholder of TSR and the President, director and a shareholder of QAR (“Fitzgerald”), and Bradley Tirpak, a shareholder and the chairman of the board of directors of TSR (“Tirpak”). The complaint purports to assert claims against the Defendants under state law and Section 10(b) of the Exchange Act in connection with a Share Purchase Agreement, dated January 31, 2021, by and between the Plaintiff, as the seller of shares of TSR’s common stock, and QAR and Tirpak, as the purchasers of such shares (the “SPA”). The plaintiff seeks (i) judgment declaring the transactions represented by the SPA null and avoid and returning the shares; (ii) judgment cancelling the SPA and returning the shares in exchange for return of the purchase price; (iii) judgement unwinding the transaction; (iv) compensatory damages; (v) punitive damages; (vi) pre-judgment interest; (vii) costs of suit including attorneys’ fees; and (viii) such other relief as the Court may find appropriate. See Note 16 to the Condensed Consolidated Unaudited Financial Statements elsewhere in this report and the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2021 for more information.
The Company believes the action described above to be without merit and intends to vigorously defend its interests. However, the Company may incur significant additional legal expenses as it pursues a vigorous defense against this action.
While the Company believes the action to be without merit, no assurances can be given as to: (i) the outcome of this or other legal proceedings and (ii) the related impact of an unanticipated adverse outcome of these proceedings on the Company’s financial condition, results of operations or near-term liquidity. |
Cash and Cash Equivalents (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of considers short-term highly liquid investments |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marketable Securities (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments, Debt and Equity Securities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of major categories of assets measured at fair value on a recurring basis |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of marketable securities |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of future minimum lease payments under non-cancellable operating leases |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of right-of-use assets and operating lease liabilities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Geneva Consulting Group Acquisition (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||||||||||
| Business Combinations [Abstract] | ||||||||||||||||||||||||||||||||||||
| Schedule of purchase price at fair values |
|
|||||||||||||||||||||||||||||||||||
| Schedule of allocation of purchase price at estimated fair values |
|
|||||||||||||||||||||||||||||||||||
| Schedule of Unaudited pro forma financial information |
|
|||||||||||||||||||||||||||||||||||
Intangible Assets (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of intangible assets identified in the Geneva acquisition |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income (Loss) Per Common Share (Details) - shares |
3 Months Ended | 9 Months Ended |
|---|---|---|
Feb. 28, 2022 |
Feb. 28, 2022 |
|
| Earnings Per Share [Abstract] | ||
| Restricted stock awards | 84,293 | 83,830 |
Cash and Cash Equivalents (Details) - Schedule of considers short-term highly liquid investments - USD ($) |
Feb. 28, 2022 |
May 31, 2021 |
|---|---|---|
| Schedule of considers short-term highly liquid investments [Abstract] | ||
| Cash in banks | $ 5,941,186 | $ 7,317,517 |
| Money market funds | 545,019 | 53,129 |
| Total | $ 6,486,205 | $ 7,370,646 |
Marketable Securities (Details) - Schedule of major categories of assets measured at fair value on a recurring basis - USD ($) |
Feb. 28, 2022 |
May 31, 2021 |
|---|---|---|
| Marketable Securities (Details) - Schedule of major categories of assets measured at fair value on a recurring basis [Line Items] | ||
| Equity Securities | $ 38,160 | $ 45,696 |
| Level 1 [Member] | ||
| Marketable Securities (Details) - Schedule of major categories of assets measured at fair value on a recurring basis [Line Items] | ||
| Equity Securities | 38,160 | $ 45,696 |
| Level 2 [Member] | ||
| Marketable Securities (Details) - Schedule of major categories of assets measured at fair value on a recurring basis [Line Items] | ||
| Equity Securities | ||
| Level 3 [Member] | ||
| Marketable Securities (Details) - Schedule of major categories of assets measured at fair value on a recurring basis [Line Items] | ||
| Equity Securities |
Marketable Securities (Details) - Schedule of marketable securities - USD ($) |
9 Months Ended | |
|---|---|---|
Feb. 28, 2022 |
May 31, 2021 |
|
| Schedule of marketable securities [Abstract] | ||
| Equity Securities, Amortized Cost | $ 16,866 | $ 16,866 |
| Equity Securities, Gross Unrealized Holding Gains | 21,294 | 28,830 |
| Equity Securities, Gross Unrealized Holding Losses | ||
| Equity Securities, Recorded Value | $ 38,160 | $ 45,696 |
Leases (Details) - USD ($) |
6 Months Ended | 9 Months Ended | |
|---|---|---|---|
Nov. 30, 2020 |
Feb. 28, 2022 |
Feb. 28, 2021 |
|
| Leases [Abstract] | |||
| Lease expiration, description | The lease agreements for New York City, Hauppauge and New Jersey expire on August 31, 2022, December 31, 2023 and May 31, 2027, respectively, and do not include any renewal options. During the fiscal year ended May 31, 2021, the Company extended its lease in Hauppauge, entered into a lease in a new location for its New Jersey office expiring May 31, 2027 and entered into an agreement to sublease the space in New York City expiring August 31, 2022. | ||
| Right-of-use asset impairment charge | $ 136,599 | $ 136,599 | |
| Operating lease expense | $ 240,000 | $ 352,000 | |
| Operating lease, weighted average remaining lease term | 2 years 10 months 24 days | ||
Leases (Details) - Schedule of future minimum lease payments under non-cancellable operating leases |
Feb. 28, 2022
USD ($)
|
|---|---|
| Schedule of future minimum lease payments under non-cancellable operating leases [Abstract] | |
| 2023 | $ 295,519 |
| 2024 | 203,248 |
| 2025 | 123,085 |
| 2026 | 126,162 |
| 2027 | 129,316 |
| Thereafter | 32,527 |
| Total undiscounted operating lease payments | 909,857 |
| Less imputed interest | 122,471 |
| Present value of operating lease payments | $ 787,386 |
Leases (Details) - Schedule of right-of-use assets and operating lease liabilities |
9 Months Ended |
|---|---|
|
Feb. 28, 2022
USD ($)
| |
| Assets | |
| Right-of-use assets, net | $ 713,413 |
| Liabilities | |
| Current operating lease liabilities | 249,688 |
| Long-term operating lease liabilities | 537,698 |
| Total operating lease liabilities | $ 787,386 |
Credit Facility (Details) - USD ($) |
1 Months Ended | 9 Months Ended |
|---|---|---|
Nov. 27, 2019 |
Feb. 28, 2022 |
|
| Credit Facility (Details) [Line Items] | ||
| Borrowed amount under credit facility | $ 2,000,000 | |
| Line of credit facility, description | Advances under the Credit Facility accrue interest at a rate per annum equal to (x) the “base rate” or “prime rate” announced by Citibank, N.A. from time to time, which shall be increased or decreased, as the case may be, in an amount equal to each increase or decrease in such “base rate” or “prime rate,” plus (y) 1.75%. The prime rate as of February 28, 2022 was 3.25%, indicating an interest rate of 5.0% on the line of credit. The initial term of the Credit Facility is five years, which shall automatically renew for successive five-year periods unless either TSR or the Lender gives written notice to the other of termination at least 60 days prior to the expiration date of the then-current term. | |
| Net borrowings outstanding | $ 60,000 | |
| Loan and Security Agreement [Member] | ||
| Credit Facility (Details) [Line Items] | ||
| Borrowed amount under credit facility | $ 7,000,000 | |
| Credit Facility [Member] | ||
| Credit Facility (Details) [Line Items] | ||
| Borrowed amount under credit facility | $ 2,000,000 |
Termination of Former CEO (Details) - USD ($) |
1 Months Ended | 9 Months Ended |
|---|---|---|
Oct. 31, 2021 |
Feb. 28, 2022 |
|
| Termination of Former CEO [Abstract] | ||
| Enhanced severance amount, description | (1) breach of his employment contract; and (2) breach of duty of good faith and fair dealing. Plaintiff Hughes alleged that he was terminated without cause or in the alternative that he resigned for good reason and therefore, pursuant to the Employment Agreement, Hughes sought severance pay in the amount of $1,000,000 and reasonable costs and attorney’s fees. The Company denied Plaintiff’s allegations in their entirety and filed counterclaims against Plaintiff for (1) declaratory relief; (2) breach of confidence/non-compete agreement; (3) declaratory and injunctive relief – confidence/non-compete; (4) tortious interference with current and prospective contractual and economic relations; (5) breach of fiduciary duty; (6) misappropriation of trade secrets; (7) declaratory and injunctive relief – unfair competition; and (8) conversion. | |
| Discovery expenses | $ 705,000 | |
| Selling, general and administrative expenses, description | After adjusting for insurance reimbursement, the Company accrued a charge of $580,000 to selling, general and administrative expenses in the quarter ended August 31, 2021 and nine months ended February 28, 2022. |
Legal Settlement with Investor (Details) - USD ($) |
9 Months Ended | ||||
|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Apr. 01, 2020 |
Feb. 28, 2022 |
Feb. 29, 2020 |
|
| Legal Settlement with Investor (Details) [Line Items] | |||||
| Legal settlement amount payable | $ 900,000 | ||||
| Settlement period | 3 years | ||||
| Cash payment | $ 300,000 | ||||
| Due payment | $ 300,000 | ||||
| Accrued interest rate, percentage | 3.75% | ||||
| Estimated present value of payments | $ 818,000 | ||||
| Effective interest rate | 5.00% | ||||
| Estimated present value of payments | $ 590,000 | ||||
| Forecast [Member] | Second Cash Payment [Member] | |||||
| Legal Settlement with Investor (Details) [Line Items] | |||||
| Cash payment | $ 300,000 | ||||
| Forecast [Member] | Third Cash Payment [Member] | |||||
| Legal Settlement with Investor (Details) [Line Items] | |||||
| Cash payment | $ 300,000 |
Paycheck Protection Program Loan (Details) - Paycheck Protection Program [Member] - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended |
|---|---|---|---|
Apr. 15, 2020 |
Aug. 31, 2021 |
Feb. 28, 2022 |
|
| Paycheck Protection Program Loan (Details) [Line Items] | |||
| Proceeds from loan | $ 6,659,220 | ||
| Other income | $ 6,735,246 | $ 6,735,246 |
Geneva Consulting Group Acquisition (Details) - USD ($) |
1 Months Ended | 9 Months Ended |
|---|---|---|
Mar. 17, 2021 |
Feb. 28, 2022 |
|
| Geneva Consulting Group Acquisition (Details) [Line Items] | ||
| Acquisition, description | The purchase price for the shares of Geneva was comprised of the following: (i) $1,452,000 in cash paid to Sellers at the closing of the acquisition, (ii) an amount of $748,000, which was equal to the amount of Geneva’s loan under the PPP that was not assumed by the Company and was substantially forgiven by the SBA, (iii) an amount up to $300,000, originally payable paid as an earnout payment in part in February 2021 and in part in August 2021 (the “Earnout Payments”), (iv) bonus payments payable in $10,000 increments, (v) $747,000 for the net working capital of Geneva as of closing and (vi) other purchase price adjustments of which $36,000 has been paid to date. Any Earnout Payments and bonus payments were to be determined based upon the achievement of certain criteria relating to the number the Company’s contractors working full-time at the Company’s client locations on such dates. | |
| Earnout payments, description | Pursuant to this agreement, and in full satisfaction of the Company’s obligations for deferred payments under the purchase agreement for the Geneva acquisition, the Sellers’ representative acknowledged receipt of the first Earnout Payment in the amount of $100,000, the parties agreed that the Company would make aggregate bonus payments to the Sellers’ representatives in the amount of $260,000, and the Company agreed to instruct the escrow agent to release to the Sellers’ representatives the second Earnout Payment in the amount of $200,000. | |
| Selling, general and administrative expenses | $ 210,000 | |
| Payment for bonus | $ 210,000 | |
| Geneva acquisition [Member] | ||
| Geneva Consulting Group Acquisition (Details) [Line Items] | ||
| Other expenses | $ 498,000 |
Geneva Consulting Group Acquisition (Details) - Schedule of purchase price at fair values |
9 Months Ended |
|---|---|
|
Feb. 28, 2022
USD ($)
| |
| Schedule of purchase price at fair values [Abstract] | |
| Cash consideration paid to date | $ 2,983,264 |
| Estimated earnout and other liabilities | 358,796 |
| Total purchase price | $ 3,342,060 |
Geneva Consulting Group Acquisition (Details) - Schedule of allocation of purchase price at estimated fair values |
Feb. 28, 2022
USD ($)
|
|---|---|
| Schedule of allocation of purchase price at estimated fair values [Abstract] | |
| Cash | $ 241,946 |
| Accounts receivable | 778,930 |
| Prepaid expenses | 5,249 |
| Intangible assets (see Note 15) | 1,800,000 |
| Goodwill | 785,883 |
| Accrued expenses | (269,948) |
| Net assets | $ 3,342,060 |
Geneva Consulting Group Acquisition (Details) - Schedule of Unaudited pro forma financial information |
9 Months Ended |
|---|---|
|
Feb. 28, 2022
USD ($)
$ / shares
| |
| Schedule of Unaudited pro forma financial information [Abstract] | |
| Revenue | $ 49,180 |
| Net loss | $ (779) |
| Diluted loss per share (in Dollars per share) | $ / shares | $ (0.4) |
Related Party Transactions (Details) - $ / shares |
Feb. 03, 2021 |
Jan. 05, 2021 |
|---|---|---|
| Related Party Transactions (Details) [Line Items] | ||
| Common stock outstanding percentage | 5.00% | |
| Chairman [Member] | ||
| Related Party Transactions (Details) [Line Items] | ||
| Share purchased | 27,586 | |
| QAR Industries, Inc. [Member] | ||
| Related Party Transactions (Details) [Line Items] | ||
| Share purchased | 348,414 | |
| Fintech Consulting LLC [Member] | ||
| Related Party Transactions (Details) [Line Items] | ||
| Common stock price per share | $ 7.25 | |
| Fintech Consulting LLC [Member] | Chairman [Member] | ||
| Related Party Transactions (Details) [Line Items] | ||
| Common stock price per share | $ 7.25 |
Stock-Based Compensation Expense (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended |
|---|---|---|---|
Jan. 28, 2021 |
Feb. 28, 2022 |
Feb. 28, 2022 |
|
| Stock-Based Compensation Expense (Details) [Line Items] | |||
| Shares granted (in Shares) | 108,333 | ||
| Stock option vested (in Shares) | 69,167 | ||
| Shares granted | $ 826,000 | ||
| Option granted based on the closing price | $ 262,000 | ||
| Stock based compensation expense | $ 141,000 | $ 496,000 | |
| Compensation expense, description | As of February 28, 2022, there is approximately $356,000 of unearned compensation expense that will be expensed through February 2024; 142,666 stock awards expected to vest; 56,666 awards vested to date, of which 14,780 were forfeited to pay taxes applicable to the stock awards. | ||
| Minimum [Member] | |||
| Stock-Based Compensation Expense (Details) [Line Items] | |||
| Estimated forfeiture rates | 40.00% | ||
| Maximum [Member] | |||
| Stock-Based Compensation Expense (Details) [Line Items] | |||
| Estimated forfeiture rates | 60.00% |
Common Stock (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Oct. 08, 2021 |
Feb. 28, 2022 |
Feb. 28, 2022 |
May 31, 2021 |
|
| Common Stock (Details) [Line Items] | ||||
| Common stock authorizes | 12,500,000 | 12,500,000 | 12,500,000 | |
| Common stock par value per share | $ 0.01 | $ 0.01 | $ 0.01 | |
| Common stock, description | The $4,167,000 of common stock that may be offered, issued and sold under the sales agreement prospectus is included in the $5,000,000 of shares of common stock that may be offered, issued and sold by the Company under the base prospectus. Upon termination of the sales agreement, any portion of the $4,167,000 included in the sales agreement prospectus that is not sold pursuant to the sales agreement will be available for sale in other offerings pursuant to the base prospectus and if no shares are sold under the agreement, the full $4,167,000 of securities may be sold in other offerings pursuant to the base prospectus. Under the 2021 ATM, we pay the 2021 Agent a commission rate equal to 3.0% of the gross sales price per share of all shares sold through the 2021 Agent under the sales agreement. | |||
| Common stock pursuant | 142,500 | 142,500 | ||
| Gross proceeds | $ 1,965,623 | |||
| selling price of per share | $ 13.79 | $ 13.79 | ||
| Net proceeds | $ 1,821,090 | |||
| Commissions and other transactions costs | $ 144,533 | |||
| Common stock [Member] | ||||
| Common Stock (Details) [Line Items] | ||||
| Common stock authorizes | 12,500,000 | 12,500,000 | ||
| Common stock par value per share | $ 0.01 | $ 0.01 | ||
| Common stock, description | (i) a base prospectus, which covers the offering, issuance and sale by the Company of up to $5,000,000 in the aggregate of shares of common stock from time to time in one or more offerings; and (ii) a sales agreement prospectus, which covers the offering, issuance and sale by the Company of up to $4,167,000 in the aggregate of shares of common stock that may be issued and sold from time to time under an at-the-market sales agreement (the “2021 ATM”) by and between the Company and A.G.P./Alliance Global Partners, as sales agent (the “2021 Agent”). |
Z6SM0CH7R2"_\%L#5B